A. Chichra

发表

Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCT

S. Kannan, N. Jindal, A. Bonda, 2020, Indian Journal of Hematology and Blood Transfusion.

Recent advances in childhood cancer: Fifty years of progress

A. Mahajan, Akanksha Chichra, A. Chichra, 2012 .

Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients

B. Vundinti, M. Madkaikar, S. Shabrish, 2019, Front. Immunol..

Impact of a pediatric oncology nutrition program: Lessons learnt over a decade

S. Banavali, C. Dhamne, G. Chinnaswamy, 2022, Pediatric blood & cancer.

Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma

S. Kannan, S. Gujral, P. Subramanian, 2020, International Journal of Hematology.

Non-hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer center

Sandeep Jain, Himesh Gupta, K. Das, 2011, Pediatric Surgery International.

Fludarabine Melphalan Versus Fludarabine Treosulfan As Reduced Intensity Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplant - a Retrospective Analysis

S. Kannan, A. Bonda, S. Punatar, 2019, Blood.

Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes

S. Kannan, A. Agrawal, A. Bonda, 2021, Bone Marrow Transplantation.

Comment on: The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global

S. Banavali, C. Dhamne, G. Chinnaswamy, 2020, Pediatric blood & cancer.

COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection

S. Banavali, C. Dhamne, G. Chinnaswamy, 2021, Indian Journal of Pediatrics.

Psychological distress in primary caregivers of children with cancer during COVID‐19 pandemic‐A single tertiary care center experience

J. Deodhar, S. Goswami, S. Banavali, 2021, Psycho-oncology.

Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML).

Meenakshi Singh, A. Bonda, S. Punatar, 2021, American journal of blood research.

Granulocytic sarcoma of the lung in acute myeloid leukemia.

R. Thawani, A. Mahajan, A. Chichra, 2014, Indian pediatrics.

Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect.

P. Tembhare, N. Jindal, L. Hingorani, 2023, International immunopharmacology.

Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab.

P. Subramanian, P. Tembhare, A. Bonda, 2021, American Journal of Blood Research.

Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant

N. Jindal, S. Punatar, Anant Gokarn, 2023, BLOOD CELL THERAPY / The official journal of APBMT.

Clinical characteristics, laboratory parameters and outcomes of COVID‐19 in cancer and non‐cancer patients from a tertiary Cancer Centre in India

S. Kannan, S. Nair, Sudeep Gupta, 2021, Cancer medicine.

KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.

G. Chatterjee, P. Tembhare, C. Dhamne, 2023, Pediatric blood & cancer.

Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with Chemotherapy.

P. Subramanian, P. Tembhare, S. Banavali, 2023, Indian journal of pediatrics.